Related Experiment Video
Updated: Jun 19, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone homeostasis
Youngkyun Lee1, Jeongim Ha, Hyung Joon Kim
1Department of Cell and Developmental Biology, BK21 Program and DRI, Seoul National University, 28 Yeongon-Dong, Chongno-Gu, Seoul 110-749, Korea.
Abstract:
DYRK1A is a serine/threonine kinase that has been linked to mental retardation associated with Down syndrome. In the present report, we describe a previously unknown role for DYRK1A in bone homeostasis. The protein expression of DYRK1A increased during osteoclast differentiation. In vitro studies in osteoclasts revealed that DYRK1A inhibited osteoclastogenesis. Whereas DYRK1A phosphorylated and inhibited the osteoclastogenic transcription factor NFATc1, forced expression of NFATc1 induced DYRK1A expression, suggesting a negative feedback loop. Transgenic mice overexpressing DYRK1A by the extent of the increased gene dosage in Down syndrome exhibited significantly reduced bone mass despite the decreased osteoclastogenesis, which is reminiscent of osteoporotic bone phenotype in Down syndrome patients. In these mice, attenuated osteoblast differentiation and function in the presence of extra DYRK1A overrode the effect of impaired osteoclastogenesis. However, impeded osteoclastogenesis in DYRK1A transgenic mice was proven to be beneficial in protecting bone loss induced by inflammation or estrogen deficiency. These results provide novel insight into the role for DYRK1A in bone homeostasis as well as in bone destructive diseases, in which modulation of DYRK1A might be used as a strategy to treat unregulated bone resorption.
Insights
DYRK1A kinase, linked to Down syndrome, plays a novel role in bone health. Overexpression impairs bone mass by affecting osteoblasts, but protects against bone loss in certain conditions.
Area of Science:
- Molecular Biology
- Bone Biology
- Genetics
Background:
- DYRK1A (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A) is known for its role in cognitive development, particularly in Down syndrome.
- Its function in bone homeostasis has not been previously elucidated.
Purpose of the Study:
- To investigate the role of DYRK1A in bone homeostasis and its potential involvement in bone-related diseases.
- To explore the molecular mechanisms by which DYRK1A influences osteoclast and osteoblast function.
Main Methods:
- In vitro studies using osteoclasts to assess DYRK1A's effect on osteoclastogenesis.
- Analysis of DYRK1A phosphorylation of NFATc1 and the feedback loop.
- Generation and analysis of transgenic mice overexpressing DYRK1A.
Main Results:
- DYRK1A expression increased during osteoclast differentiation and inhibited osteoclastogenesis by phosphorylating NFATc1.
- Overexpression of DYRK1A in mice led to reduced bone mass, mimicking Down syndrome phenotypes, due to impaired osteoblast function.
- Inhibited osteoclastogenesis in DYRK1A transgenic mice offered protection against inflammation- or estrogen deficiency-induced bone loss.
Conclusions:
- DYRK1A plays a significant role in regulating bone homeostasis, impacting both osteoclast and osteoblast lineages.
- DYRK1A's dual role suggests potential therapeutic strategies for bone destructive diseases by modulating its activity.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Bone Remodeling
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...